SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001437749-22-028938
Filing Date
2022-12-13
Accepted
2022-12-12 18:35:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A auer20221212_sc13da.htm SC 13D/A 46076
  Complete submission text file 0001437749-22-028938.txt   47455
Mailing Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024
Business Address
AUERBACH ALAN H (Filed by) CIK: 0001358285 (see all company filings)

Type: SC 13D/A

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Subject) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83367 | Film No.: 221458190
SIC: 2834 Pharmaceutical Preparations